Elon Musk's Neuralink
Stay connected with the biggest global stories in business and tech. Presented by Karleen Leveille, every weekday on Curio. In today's episode... Is $9bn enough compensation for thousands impacted by alleged cancer-causing talc? The Wall Street Journal breaks down the history and facts behind what could be one of the biggest product-liability settlements ever. Then, could Bayer's new CEO be exactly what they need? Still struggling with the fallout from an ill-fated 2016 acquisition, the Financial Times discovers plans to save the conglomerate as investors push for a breakup.